Neha Bhasin Hoer, MD

I am a Pediatric Hematologist/Oncologist with subspecialty interest in Pediatric Hematology. I am the Medical Director for the Pediatric Sickle Cell Program in Oakland. My clinical interests include Sickle Cell Disease, Bleeding, Thrombosis, Iron Deficiency anemia and other Cytopenias. My research focuses on the needs of my patients specifically women's health, coagulopathy in sickle cell disease and acute chest syndrome.
Education
06/2014 - Certificate in Clinical and Translational Research, University of Iowa
06/2013 - Fellowship, Pediatric Hematology/Oncology, University of Iowa
06/2010 - Residency, Pediatrics, Stony Brook University Medical Center
MD, 06/2007 - Medicine, Ross University
  1. Rush G, Mohamed RE, Moffatt-Bazile K, Jamalapur SL, Valenti GG, Sathi BK, Jacob S, Van Doren LN, Velez MC, Ogu U, Smink GM, Schultz CL, DiVirgilio N, Gomez E, Quarmyne MO, Light J, Gupta K, Zhang L, Vichinsky EP, Hagar W, Rivers A, Treadwell M, Strouse JJ, Bhasin N. Role of Menstrual Bleeding Assessments in Sickle Cell Clinics. JAMA network open 2025. PMID: 41364436


  2. Schlenz AM, Phillips SM, Mueller M, Humphrey D, Stevens J, Williams LP, Nickel RS, Dolatshahi L, Miller RE, Hulbert ML, Lee MT, Alvarez O, Fuh B, McNaull MA, Bhasin N, Melvin CL, Adams RJ, Kanter J. Successful implementation of stroke risk screening for sickle cell anemia in the DISPLACE study: results of a cluster randomized trial. Implementation science : IS 2025. PMID: 41299691


  3. Jacob SA, Frei-Jones M, Saif-Ur-Rehman S, Hulbert ML, O'Brien ARW, Strunk C, Villella A, Talati R, Owusu-Ansah A, Coyne F, McGann PT, Rai P, Miller R, Rampersad A, Sakhalkar V, Bhasin N, Manwani D, Lanzkron S, Kanter J. National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance: A Consensus Statement. JAMA network open 2025. PMID: 41231476


  4. Hildenbrand AK, Mara CA, Murphy B, Hood AM, Johnson Y, Shook LM, Real FJ, Nwankwo C, Hackworth R, Badawy SM, Thompson AA, Raphael JL, Smith-Whitley K, King AA, Calhoun C, Creary SE, Reader SK, Bhasin N, Sobota AE, Houston P, Gipson C, DeBaun MR, Saving KL, Treadwell M, Quinn CT, Crosby LE. Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study. Pediatric blood & cancer 2025. PMID: 40051208



  5. Bhasin N, LeBlanc DM, Yates S, Eichbaum Q, Pham A, Sharma D, Zhang L, Vichinsky EP, Sarode R. Physician perspectives about the diagnosis and management of acute chest syndrome. Transfusion 2024. PMID: 39373054


  6. Davidow KA, Miller R, Phillips SM, Schlenz AM, Mueller M, Hulbert ML, Hsu LL, Bhasin N, Adams RJ, Kanter J. DISPLACE Study Shows Poor Quality of Transcranial Doppler Ultrasound for Stroke Risk Screening in Sickle Cell Anemia. Blood advances 2024. PMID: 38669350


  7. Kanter J, Ataga KI, Bhasin N, Guarino S, Kutlar A, Lanzkron S, Manwani D, McGann P, Stowell SR, Tubman VN, Yermilov I, Campos C, Broder MS. Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel. Annals of hematology 2024. PMID: 38642304




  8. Treadwell MJ, Du L, Bhasin N, Marsh AM, Wun T, Bender MA, Wong TE, Crook N, Chung JH, Norman S, Camilo N, Cavazos J, Nugent D. Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative. Frontiers in genetics 2022. PMID: 36092883


  9. Bhasin N, Roe DJ, Saboda K, Journeycake J, Moreno V, Lentz SR. Association of low serum albumin with venous thrombosis in pediatric patients. Thrombosis research 2022. PMID: 35988444



  10. Cabana MD, Marsh A, Treadwell MJ, Stemmler P, Rowland M, Bender MA, Bhasin N, Chung JH, Hassell K, Abdul Rashid NFN, Wong TE, Bardach NS. Improving Preventive Care for Children With Sickle Cell Anemia: A Quality Improvement Initiative. Pediatric quality & safety 2020. PMID: 33409431



  11. Niki M, Nayak MK, Jin H, Bhasin N, Plow EF, Pandolfi PP, Rothman PB, Chauhan AK, Lentz SR. Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice. 2016. PMID: 26790499